Ab initio study on the molecular structure of trans-1,2-dihydroxy-1,2-dihydro-8-fluoronaphthalene

Belend, 1984, Ab initio study on the molecular structure of the naphthalene metabolite, trans-1,2-dihydroxy-1,2-dihydronaphthalene, Carcinogenesis, 5, 1097, 10.1093/carcin/5.8.1097 Buening, 1983, Fluorine substitution as a probe for the role of the 6-position of benzo[a]pyrene in carcinogenesis, J. Natl. Cancer Inst., 71, 309 Buhler, 1982, Metabolism and tumorigenicity of 7-, 8-, 9- and 10-fluorobenzo(a)pyrenes, Cancer Res., 42, 4779 Buhler, 1983, Effect of a 6-fluoro substituent on the metabolism and biological activity of benzo(a)pyrene, Cancer Res., 43, 1541 Chiu, 1982, Effect of a peri fluoro substituent on the conformation of dihydrodiol derivatives of polycyclic aromatic hydrocarbons, Biochem. Biophys. Res. Commun., 106, 1405, 10.1016/0006-291X(82)91270-0 Chiu, 1984, Stereoselectivity of rat liver microsomal enzymes in the metabolism of 7-fluorobenz(a)anthracene and mutagenicity of metabolites, Cancer Res., 44, 562 Conney, 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture, Cancer Res., 42, 4875 DiGiovanni, 1982, Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice, Carcinogenesis, 3, 651, 10.1093/carcin/3.6.651 Ditchfield, 1971, An extended gaussian-type basis for molecular orbital studies of organic molecules, J. Chem. Phys., 54, 724, 10.1063/1.1674902 Hecht, 1978, Tumor-initiating activity of fluorinated 5-methylchrysenes, Cancer Res., 38, 1694 Hecht, 1979, Comparative mutagenicity, tumor-initiating activity, carcinogenicity and in vitro metabolism of fluorinated 5-methylchrysenes, J. Natl. Cancer Inst., 63, 855, 10.1093/jnci/63.3.855 Hecht, 1985, Effects of methyl and fluorine substitution on the metabolic activation and tumorigenicity of polycyclic aromatic hydrocarbons, 85 Huberman, 1979, Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz(a)anthracene, Cancer Res., 39, 411 Jerina, 1985, Stereoselective metabolism of polycyclic aromatic hydrocarbons to carcinogenic metabolites, 310 Klimkowski, 1982, Molecular orbital constrained electron diffraction studies. 4. Conformational analysis of the methyl ester of glycine, J. Am. Chem. Soc., 104, 1476, 10.1021/ja00370a004 Miller, 1960, The carcinogenicity of fluoro derivatives of 10-methyl-1,2-benzanthracene. I. 3- and 4′-monofluoro derivatives, Cancer Res., 20, 133 Miller, 1963, The carcinogenicities of fluoro derivatives of 10-methyl-1,2-benzanthracene. II. Substitution of the K region and the 3′-, 6-, 7-positions, Cancer Res., 23, 229 Pulay, 1969, Ab initio calculation of force constants and equilibrium geometries in polyatomic molecules. I. Theory, Mol. Phys., 17, 197, 10.1080/00268976900100941 Pulay, 1979, An efficient ab initio gradient program, Theor. Chim. Acta, 50, 299, 10.1007/BF00551337 Pulay, 1979, Systematic ab initio gradient calculation of molecular geometries, force constants, and dipole moment derivatives, J. Am. Chem. Soc., 101, 2550, 10.1021/ja00504a009 Sayer, 1984, Conformational effects in the hydrolyses of benzo-ring diol epoxides that have bay-region diol groups, J. Am. Chem. Soc., 106, 226, 10.1021/ja00313a044 Schäfer, 1983, The ab initio gradient revolution in structural chemistry, J. Mol. Struct., 100, 51, 10.1016/0022-2860(83)90083-2 Slaga, 1979, The importance of the “bay region” diol-epoxide in 7,12-dimethylbenz[a]anthracene skin tumor initiation and mutagenesis, Cancer Letters, 6, 213, 10.1016/S0304-3835(79)80036-1 Thakker, 1984, Effects of a 6-fluoro substituent on the metabolism of benzo(a)pyrene 7,8-dihydrodiol to bay-region diol epoxides by rat liver enzymes, J. Biol. Chem., 259, 11249, 10.1016/S0021-9258(18)90855-0 Wood, 1982, Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes, J. Natl. Cancer Inst., 69, 725 Yang, 1980, Metabolic and structural requirements for the carcinogenic potencies of unsubstituted and methyl-substituted polycyclic aromatic hydrocarbons, 143